Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Plasma levels of amyloid beta proteins did not differ between subjects taking statins and those not taking statins.

Literature DB >> 11310640

Plasma levels of amyloid beta proteins did not differ between subjects taking statins and those not taking statins.

T Tokuda, A Tamaoka, S Matsuno, S Sakurai, H Shimada, H Morita, S Ikeda.

Abstract

Mesh：

Substances：

Year: 2001 PMID： 11310640

Source DB: PubMed Journal: Ann Neurol ISSN： 0364-5134 Impact factor: 10.422

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

Review 1. Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.

Authors: Meaghan C Creed; Norton W Milgram
Journal: Age (Dordr) Date: 2010-04-20

2. Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease.

Authors: Kina Höglund; Steinar Syversen; Piotr Lewczuk; Anders Wallin; Jens Wiltfang; Kaj Blennow
Journal: Exp Brain Res Date: 2005-06-04 Impact factor: 1.972

3. Identification of differently expressed genes in human colorectal adenocarcinoma.

Authors: Yao Chen; Yi-Zeng Zhang; Zong-Guang Zhou; Gang Wang; Zeng-Ni Yi
Journal: World J Gastroenterol Date: 2006-02-21 Impact factor: 5.742

4. Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers.

Authors: Alberto Serrano-Pozo; Gloria L Vega; Dieter Lütjohann; Joseph J Locascio; Marsha K Tennis; Amy Deng; Alireza Atri; Bradley T Hyman; Michael C Irizarry; John H Growdon
Journal: Alzheimer Dis Assoc Disord Date: 2010 Jul-Sep Impact factor: 2.703

10. Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study.

Authors: T T Seppälä; S-K Herukka; T Hänninen; S Tervo; M Hallikainen; H Soininen; T Pirttilä
Journal: J Neurol Neurosurg Psychiatry Date: 2010-05-16 Impact factor: 10.154

Plasma levels of amyloid beta proteins did not differ between subjects taking statins and those not taking statins.

Review 1. Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.

2. Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease.

3. Identification of differently expressed genes in human colorectal adenocarcinoma.

4. Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers.

Review 5. Biomarkers of Alzheimer disease in plasma.

Review 6. Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.

7. CHOLESTEROL AND NEURONAL SUSCEPTIBILITY TO BETA-AMYLOID TOXICITY.

Review 8. Current and emerging drug treatment options for Alzheimer's disease: a systematic review.

Review 9. ACAT inhibition and amyloid beta reduction.

10. Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study.